The Product Strategy and Market Access team at Kyowa Kirin International plc. plays a pivotal role in ensuring the successful launch and sustained market presence of innovative medicines. This team is responsible for developing comprehensive product strategies, conducting market analyses, and optimizing market access to meet the needs of patients and healthcare providers. They collaborate with various stakeholders to navigate the regulatory landscape, secure reimbursement approvals, and establish value propositions for new and existing products in the therapy areas of oncology, nephrology, and central nervous system (CNS) across Europe and the Middle East.
View all